Brandinium

Trademark search for:

AMYRIAD THERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-11-03 — Application filed
  • 2021-11-06 — Application filed
  • 2021-11-15 — Application filed
  • 2022-08-12 — Assigned to examiner
  • 2022-08-19 — Final disposition recorded
  • 2022-08-19 — Final disposition recorded
  • 2022-08-19 — Final disposition recorded
  • 2023-02-17 — Office action issued
  • 2023-02-17 — Correspondence received in law office
  • 2023-02-18 — Teas/email correspondence entered
  • 2023-02-27 — Suspension letter written
  • 2023-02-27 — Letter of suspension e-mailed
  • 2023-02-27 — Notification of letter of suspension e-mailed
  • 2023-10-13 — Report completed suspension check case still suspended
  • 2024-01-12 — Assigned to examiner
  • 2024-04-15 — Suspension checked - to attorney for action
  • 2024-05-16 — Final disposition recorded
  • 2024-05-16 — Final disposition recorded
  • 2024-05-16 — Final disposition recorded
  • 2024-08-14 — Application filed
  • 2024-08-14 — Application filed
  • 2024-11-15 — Office action issued
  • 2024-11-15 — Correspondence received in law office
  • 2024-11-15 — Teas/email correspondence entered
  • 2024-12-06 — Suspension letter written
  • 2024-12-06 — Letter of suspension e-mailed
  • 2024-12-06 — Notification of letter of suspension e-mailed
  • 2025-06-08 — Suspension checked - to attorney for action
  • 2025-06-11 — Suspension inquiry written
  • 2025-06-11 — Inquiry to suspension e-mailed
  • 2025-06-11 — Notification of inquiry as to suspension e-mailed
  • 2025-09-09 — Application filed
  • 2025-09-09 — Application filed
  • 2026-01-02 — Application abandoned
  • 2026-01-02 — Application abandoned
  • 2026-01-02 — Final status recorded

Owner Information

AmyriAD Therapeutics B.V.
Los Angeles , CA

Correspondent

John Paul Oleksiuk COOLEY LLP
1299 PENNSYLVANIA AVENUE, NW, SUITE 700
WASHINGTON, DC 20004
United States

Filing Details

Filing Date:
2021-11-03
Status Date:
2026-01-02
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.